Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 6Pain, Postoperative 5Brain Neoplasms 5Lung Neoplasms 3Delirium 3Uterine Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Kidney Neoplasms 2Depression 2Carcinoma, Non-Small-Cell Lung 2Vomiting 1Thromboembolism 1Synovial Cyst 1Surgical Wound Infection 1Supratentorial Neoplasms 1Supratentorial Brain Tumor 1Stomach Neoplasms 1Spondylosis 1Spondylolisthesis 1Spinal Stenosis 1Sleep Initiation and Maintenance Disorders 1Sleep Deprivation 1Scleroderma, Localized 1Radiculopathy 1Prostatic Neoplasms 1Postoperative Hemorrhage 1Pituitary Neoplasms 1Pituitary Diseases 1Otolaryngeal Cancer 1

Interventions

Sodium Chloride 1Saline Solution 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Neurocognitive Disorders × Saline Solution × Clear all
NCT02810899 2016-09-29

Dexmedetomidine and Intelligence Development in Pediatric Patients Undergoing Craniotomy

Peking University First Hospital

Phase 4 Completed
60 enrolled
CNS

Brain Neoplasms, Neurocognitive Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡